These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9454073)

  • 21. [Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12].
    Tumanova OIu; Kuvshinov VN; Il'ichev AA; Nekrasov BG; Ivanisenko VA; Kozlov AP; Sandakhchiev LS
    Mol Biol (Mosk); 2002; 36(4):657-63. PubMed ID: 12173470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the immunologic heterogeneity of HIV-1. II. Effect of amino acid residues, flanking the C-terminus of the central tetrapeptide loop V3 of gp120].
    Shchelkanov MIu; Iaroslavtseva NG; Iudin AN; Eremin VF; Pyzhova NS; Semiletov IuA; Abélian AV; Titov LP; Karamov EV
    Mol Biol (Mosk); 1998; 32(4):729-34. PubMed ID: 9785579
    [No Abstract]   [Full Text] [Related]  

  • 23. NMR study of the peptide present in the principal neutralizing determinant (PND) of HIV-1 envelope glycoprotein gp120.
    Sarma AV; Raju TV; Kunwar AC
    J Biochem Biophys Methods; 1997 Mar; 34(2):83-98. PubMed ID: 9178085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.
    Tugarinov V; Zvi A; Levy R; Anglister J
    Nat Struct Biol; 1999 Apr; 6(4):331-5. PubMed ID: 10201400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
    Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
    Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Conformational analysis of major antigenic determinant of HIV-1 gp120 protein using the NMR spectroscopy data].
    Andrianov AM
    Mol Biol (Mosk); 1996; 30(5):1173-83. PubMed ID: 8992304
    [No Abstract]   [Full Text] [Related]  

  • 28. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.
    Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF
    Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
    Kanyalkar M; Srivastava S; Saran A; Coutinho E
    J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant gp120, antibodies to the V3 region of gp120, and neural progenitor cells.
    Klasse PJ; Barnes KC; Moore JP
    J Infect Dis; 2005 Mar; 191(5):815-6; author reply 816-8. PubMed ID: 15688301
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of the immunologic heterogeneity of HIV-1: I. "Arginine-glutamine trigger" in the fourth position of the central tetrapeptide of the V3 loop of gp120].
    Shchelkanov MIu; Iaroslavtseva NG; Iudin AN; Eremin VF; Pyzhova NS; Semiletov IuA; Abélian AV; Titov LP; Karamov EV
    Mol Biol (Mosk); 1998; 32(4):717-28. PubMed ID: 9785578
    [No Abstract]   [Full Text] [Related]  

  • 37. Stabilization of the biologically active conformation of the principal neutralizing determinant of HIV-1(IIIB) containing a cis-proline surrogate: 1H NMR and molecular modeling study.
    Garcia J; Dumy P; Rosen O; Anglister J
    Biochemistry; 2006 Apr; 45(13):4284-94. PubMed ID: 16566603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users.
    Saraswathy TS; Ng KP; Sinniah M
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):283-6. PubMed ID: 11127327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence analysis of the V1/V2 and V3 domains in an HIV-seronegative AIDS patient.
    Vallejo A; Bravo R; Heredia A; Soriano V; Dronda F; Hewlett IK
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1539-41. PubMed ID: 8679300
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
    Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
    J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.